Proof of Concept
Contents
- Overview
- Milestone 1: Cloning
- Milestone 2: Protein Expression and Purification
- Milestone 3: Establishing a Liquid Phase Synthesis system
- Milestone 4: ThTdT Functional Characterization
- Milestone 5: SPS
- Milestone 6: ThTdT-Mediated SPS
Overview
Our proof of concept (POC) aims to demonstrate that storing data in DNA can be transformed into a feasible and viable product. In this section, we detail design of our POC, including tangible criteria for success, with the eventual goal of being able to encode, synthesize, store and decode DNA sequences of 150 nucleotides long. We describe our decision-making process and outline the checkpoints where we will seek feedback from stakeholders and reassess our objectives, along with a timeline for each step.
Milestone 1: Cloning
Our first milestone was cloning ThTdT into the pET-28b(+) plasmid. We chose pET-28b(+) since a previous study by Chua et al. (2020) succeeded in cloning terminal transferase using this plasmid 1. After several setbacks—including delayed shipments, lost reagents, incorrect E. coli strains for transformation, and cloning errors—we successfully transformed the plasmid into BL21 E. coli for high protein expression.
Milestone 2: Protein Expression and Purification
The second milestone was the expression and purification of our mutant protein ThTdT. Instead of using an HPLC, Ni-NTA magnetic beads were employed to purify the protein of interest 1. After a step-wise optimization in elution strength, we successfully expressed and purified our ThTdT within an optimized storage buffer to help extend its shelf life. In addition, by-product imidazole from the elution buffer was removed using a centrifugal filter. Protein concentration was determined using a BCA protein assay.
Milestone 3: Establishing a Liquid Phase Synthesis system
Our third milestone was the establishment of a valid liquid phases synthesis system that would allow the successful detection of DNA addition. Using WT TdT as a control, we validated that WT TdT can add nucleotides by DNA PAGE using a 5’-fluorescence labeled primer.
Milestone 4: ThTdT Functional Characterization
Our fourth milestone ThTdT was successfully produced and tested for its ability to append nucleotides at the 3’ end, using the conditions established in Milestone 3.
Milestone 5: SPS
P1 biotinylated primer was successfully immobilized on a biotinylated glass surface following Streptavidin incorporation. Imaging under Cy5 parameters shows distinct loci of immobilized clusters.
Milestone 6: ThTdT-Mediated SPS
Thermostable TdT successfully incorporated DTTP nucleotides to the immobilized primers. Following the incorporation, the DNA was cleaved from the glass and analysed through SDS-PAGE. The glass before and after cleavage following thermostable TdT extension was imaged to validate the cleavage step.
References
-
Chua, J. P. S., Go, M. K., Osothprarop, T., Mcdonald, S., Karabadzhak, A. G., Yew, W. S., Peisajovich, S., & Nirantar, S. (2020). Evolving a Thermostable Terminal Deoxynucleotidyl Transferase. ACS synthetic biology, 9(7), 1725–1735. https://doi.org/10.1021/acssynbio.0c00078 ↩ ↩2